Gennate, a Greater Manchester-based deep-tech company developing next-generation plant nutrition nanomaterials, has successfully closed a £550,000 seed funding round.
The funding will help to create up to 15 new jobs over the next three years and accelerate Gennate’s transition from laboratory development to pilot-scale manufacturing, enabling productisation of its proprietary platform and early commercial deployment. Key milestones include technology maturation, fabrication, and launch of initial industrial pilots with agritech partners.
Gennate is led by its founder and CEO, Dr Imad Naasani, and co-founder, Dr Farid Khan, both of whom are experienced biotech entrepreneurs, and they have formed a team of nanoformulation scientists. The team has moved into Kilburn House, Manchester Science Park, part of Bruntwood SciTech.
Joseph Venables, associate commercial director at Bruntwood SciTech, said, “Gennate is a fantastic example of the kind of pioneering, science-led business we’re proud to support at Manchester Science Park. By providing access to specialist lab space, a collaborative community of like-minded businesses and connections into our academic, clinical and investment partner network, we’re able to help innovators like Gennate accelerate their growth from early-stage research through to commercialisation.”
Gennate has created a novel continuous-flow nanoreactor platform to enable the low-cost, scalable production of nano-sized macro- and micronutrients. The technology addresses manufacturing and cost barriers that have limited global adoption of nanofertilisers, while enabling efficient nutrient delivery and reducing environmental losses. Gennate’s nanofertiliser formulations have already demonstrated a 30% increase in wheat seed germination and >50% yield increases in growth and biomass crops.
Dr Imad Naasani, founder and CEO of Gennate, said, “This funding is a strong validation of our scientific breakthrough and our vision to make nanotechnology commercially viable at industrial scale. It enables us to move decisively toward pilot production and sets the company for early product deployment and global growth.”
